Leerink Partners began coverage on Novogen Limited shares on October 20, 2026.
1 report, 1 independent
Updated Tue 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink Partners began coverage on Novogen Limited shares on October 20, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Leerink partners
U.S. investment bank
Related events
- Leerink Partners started coverage on Nautilus Biotechnology on October 6, 2026.
- Citigroup reissued a market outperform rating and Leerink Partners began coverage on Rapport Therapeutics.
- Leerink Partners assumed coverage on Nektar Therapeutics shares on October 13, 2026.
- Leerink Partners is a joint bookrunning manager for an offering by Retension Pharmaceuticals, Inc., with the prospectus available from Boston, MA.